Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20 Positive”

130 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 130 results

Not applicableLooking for participantsNCT06070961
What this trial is testing

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 56
Large-scale testing (Phase 3)Ended earlyNCT01287741
What this trial is testing

Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 1,418
Large-scale testing (Phase 3)Ended earlyNCT01659099
What this trial is testing

GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma CD20 Positive
The Lymphoma Academic Research Organisation 671
Early research (Phase 1)Ended earlyNCT02483000
What this trial is testing

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

Who this might be right for
Burkitt LymphomaCD20-Positive Neoplastic Cells PresentDiffuse Large B-Cell Lymphoma+4 more
Fred Hutchinson Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT04074330
What this trial is testing

TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Takeda 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06886139
What this trial is testing

TRS005 in Patients With CD20-positive R/R DLBCL.

Who this might be right for
CD20-positive Diffuse Large B-Cell Lymphoma
Zhejiang Teruisi Pharmaceutical Inc. 139
Testing effectiveness (Phase 2)UnknownNCT03456466
What this trial is testing

Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin's Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 122
Testing effectiveness (Phase 2)Study completedNCT00532129
What this trial is testing

MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 100
Testing effectiveness (Phase 2)Study completedNCT01363128
What this trial is testing

Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete RemissionBurkitt Leukemia+4 more
M.D. Anderson Cancer Center 72
Large-scale testing (Phase 3)Study completedNCT01459887
What this trial is testing

Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Shanghai CP Guojian Pharmaceutical Co., Ltd. 278
Testing effectiveness (Phase 2)Ended earlyNCT02495454
What this trial is testing

GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma

Who this might be right for
CD20 Positive Diffuse Large B-cell LymphomaElderly Unfit Patients
Fondazione Italiana Linfomi - ETS 34
Early research (Phase 1)Ended earlyNCT06248086
What this trial is testing

Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas

Who this might be right for
B-cell Lymphoma
Astellas Pharma Global Development, Inc. 1
Testing effectiveness (Phase 2)Ended earlyNCT03578198
What this trial is testing

Rituximab Plus MG4101 Indolent CD20-positive Non-Hodgkin Lymphoma (NHL)

Who this might be right for
CD20-positive Non-Hodgkin Lymphoma
Seoul National University Hospital 12
Testing effectiveness (Phase 2)UnknownNCT00397800
What this trial is testing

Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Technical University of Munich 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07035379
What this trial is testing

A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Zhejiang Teruisi Pharmaceutical Inc. 66
Large-scale testing (Phase 3)Ended earlyNCT00486759
What this trial is testing

Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Hoffmann-La Roche 787
Testing effectiveness (Phase 2)Ended earlyNCT00250861
What this trial is testing

Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
US Oncology Research 110
Testing effectiveness (Phase 2)UnknownNCT03688451
What this trial is testing

Intrathecal Rituximab With Standard Intrathecal Prophylaxis to Prevent CNS Relapse for CD 20+ Non Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Tahir Latif 20
Large-scale testing (Phase 3)Study completedNCT03976102
What this trial is testing

Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Dr. Reddy's Laboratories Limited 317
Testing effectiveness (Phase 2)Study completedNCT01015248
What this trial is testing

Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

Who this might be right for
MALT LYMPHOMA
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 60
Load More Results